Article Text

Download PDFPDF

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
  1. Davide Bedognetti1,
  2. Michele Ceccarelli2,
  3. Lorenzo Galluzzi3,4,5,
  4. Rongze Lu2,
  5. Karolina Palucka6,
  6. Josue Samayoa2,
  7. Stefani Spranger7,
  8. Sarah Warren8,
  9. Kwok-Kin Wong9,
  10. Elad Ziv10,
  11. Diego Chowell11,
  12. Lisa M. Coussens12,
  13. Daniel D. De Carvalho13,
  14. David G. DeNardo14,
  15. Jérôme Galon15,
  16. Howard L. Kaufman16,
  17. Tomas Kirchhoff17,
  18. Michael T. Lotze18,
  19. Jason J. Luke19,
  20. Andy J. Minn20,
  21. Katerina Politi21,
  22. Leonard D. Shultz22,
  23. Richard Simon23,
  24. Vésteinn Thórsson24,
  25. Joanne B. Weidhaas25,
  26. Maria Libera Ascierto26,
  27. Paolo Antonio Ascierto27,
  28. James M. Barnes2,
  29. Valentin Barsan28,
  30. Praveen K. Bommareddy29,
  31. Adrian Bot30,
  32. Sarah E. Church8,
  33. Gennaro Ciliberto31,
  34. Andrea De Maria32,
  35. Dobrin Draganov33,
  36. Winson S. Ho34,
  37. Heather M. McGee35,
  38. Anne Monette36,
  39. Joseph F. Murphy37,
  40. Paola Nisticò31,
  41. Wungki Park11,
  42. Maulik Patel2,
  43. Michael Quigley38,
  44. Laszlo Radvanyi39,
  45. Harry Raftopoulos40,
  46. Nils-Petter Rudqvist3,
  47. Alexandra Snyder41,
  48. Randy F. Sweis19,
  49. Sara Valpione42,
  50. Roberta Zappasodi47,48,
  51. Lisa H. Butterfield43,
  52. Mary L. Disis44,
  53. Bernard A. Fox45,
  54. Alessandra Cesano8,
  55. Francesco M. Marincola46,—,
  56. Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
  1. Aff1 Sidra Medicine Doha Qatar
  2. Aff2 0000 0004 0572 4227grid.431072.3AbbVie Redwood City CA USA
  3. Aff3 000000041936877Xgrid.5386.8Department of Radiation OncologyWeill Cornell Medical College New York NY USA
  4. Aff4 Sandra and Edward Meyer Cancer Center New York NY USA
  5. Aff5 0000 0001 2188 0914grid.10992.33Université Paris Descartes/Paris V Paris France
  6. Aff6 0000 0004 0374 0039grid.249880.fThe Jackson Laboratory for Genomic Medicine Farmington CT USA
  7. Aff7 0000 0001 2341 2786grid.116068.8Koch Institute for Integrative Cancer Research at MIT Cambridge MT USA
  8. Aff8 NanoString Technologies, Inc Seattle WA USA
  9. Aff9 Perlmutter Cancer CenterNew York Langone Health New York NY USA
  10. Aff10 0000 0001 2297 6811grid.266102.1University of California San Francisco CA USA
  11. Aff11 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center New York NY USA
  12. Aff12 0000 0000 9758 5690grid.5288.7Oregon Health & Science University Portland OR USA
  13. Aff13 0000 0001 2157 2938grid.17063.33Department of Medical BiophysicsPrincess Margaret Cancer Centre University Health Network, University of Toronto Toronto Canada
  14. Aff14 0000 0001 2355 7002grid.4367.6Washington University School of Medicine in St. Louis St. Louis MO USA
  15. Aff15 INSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le CancerSorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers F-75006 Paris France
  16. Aff16 Massachusetts General Hospital, BostonMA, USA and Replimune, Inc Woburn MA USA
  17. Aff17 0000 0004 1936 8753grid.137628.9Perlmutter Comprehensive Cancer CenterNew York University School of Medicine, New York University Langone Health New York New York NY USA
  18. Aff18 0000 0004 1936 9000grid.21925.3dUPMC Hillman Cancer CenterUniversity of Pittsburgh Pittsburgh PA USA
  19. Aff19 0000 0004 1936 7822grid.170205.1University of Chicago Chicago IL USA
  20. Aff20 0000 0004 1936 8972grid.25879.31Abramson Family Cancer Research InstituteUniversity of Pennsylvania Philadelphia PA USA
  21. Aff21 0000000419368710grid.47100.32Yale School of Medicine New Haven CT USA
  22. Aff22 0000 0004 0374 0039grid.249880.fThe Jackson Laboratory Cancer Center Bar Harbor ME USA
  23. Aff23 R. Simon Consulting Potomac MD USA
  24. Aff24 0000 0004 0463 2320grid.64212.33Institute for Systems Biology Seattle WA USA
  25. Aff25 0000 0000 9632 6718grid.19006.3eUniversity of California, Los Angeles Los Angeles CA USA
  26. Aff26 grid.418152.bMedImmune Gaithersberg MD USA
  27. Aff27 0000 0001 0807 2568grid.417893.0Istituto Nazionale Tumori-IRCCS Fondazione ‘G. Pascale’ Naples Italy
  28. Aff28 0000000419368956grid.168010.eStanford University Stanford CA USA
  29. Aff29 0000 0004 1936 8796grid.430387.bRutgers University New Brunswick NJ USA
  30. Aff30 grid.504964.aKite, a Gilead Company Santa Monica CA USA
  31. Aff31 0000 0004 1760 5276grid.417520.5IRCCS Istituto Nazionale Tumori Regina Elena Rome Italy
  32. Aff32 0000 0001 2151 3065grid.5606.5Università degli Studi di Genova and Ospedale Policlinico San Martino IRCCS Genoa Italy
  33. Aff33 Calidi Biotherapeutics San Diego CA USA
  34. Aff34 0000 0001 2193 0096grid.223827.eDepartment of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children’s HospitalUniversity of Utah Salt Lake City UT USA
  35. Aff35 0000 0001 0670 2351grid.59734.3cDepartment of Radiation OncologyIcahn School of Medicine at Mount Sinai New York NY USA
  36. Aff36 0000 0000 9401 2774grid.414980.0Lady Davis Institute for Medical ResearchJewish General Hospital Montreal QC Canada
  37. Aff37 Caprion Biosciences Inc Montreal QC Canada
  38. Aff38 grid.419971.3Bristol-Myers Squibb Company Redwood City CA USA
  39. Aff39 0000 0004 0626 690Xgrid.419890.dOntario Institute for Cancer Research Toronto Ontario Canada
  40. Aff40 0000 0000 8613 9871grid.419670.dBayer HealthCare Pharmaceuticals Inc Whippany NJ USA
  41. Aff41 0000 0001 2260 0793grid.417993.1Merck & Co Kenilworth NJ USA
  42. Aff42 0000000121662407grid.5379.8CRUK Manchester Institute and The Christie NHS Foundation TrustThe University of Manchester Manchester UK
  43. Aff43 grid.489192.fParker Institute for Cancer Immunotherapy San Francisco CA USA
  44. Aff44 0000000122986657grid.34477.33University of Washington Seattle WA USA
  45. Aff45 0000 0004 1936 8075grid.48336.3aEarle A. Chiles Research InstituteRobert W. Franz Cancer Center, Providence Cancer Institute Portland OR USA
  46. Aff46 Refuge Biotechnologies Inc 1505 Adams Drive, Suite D 94025 Menlo Park CA USA
  47. Aff47 0000 0001 2171 9952grid.51462.34Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center New York NY USA
  48. Aff48 0000 0001 2171 9952grid.51462.34Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center New York NY USA
  1. — franco.marincola{at}


Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.

Davide Bedognetti, Rongze Lu, Josue Samayoa, Stefani Spranger and Sarah Warren contributed equally to this work.

The original article can be found online at 10.1186/s40425-019-0602-4

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

View Full Text

Statistics from

Davide Bedognetti, Rongze Lu, Josue Samayoa, Stefani Spranger and Sarah Warren contributed equally to this work.

The original article can be found online at 10.1186/s40425-019-0602-4

Correction to: J Immuno Ther Cancer

Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.

The correction has been implemented in the original article as well.

The publisher apologized for any inconvenience this might has caused.


  1. 1.
View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.